Plasma matrix metalloproteinase 7, CC-chemokine ligand 18, and periostin as markers for pulmonary sarcoidosis

Some patients with sarcoidosis experience worsening of pulmonary lesions. However, no biomarker has been identified that reflects pulmonary disease status in sarcoidosis. We investigated the usefulness of potential markers of pulmonary fibrosis in patients with sarcoidosis. Plasma matrix metalloprot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Respiratory investigation 2020-11, Vol.58 (6), p.479-487
Hauptverfasser: Isshiki, Takuma, Matsuyama, Hisayo, Yamaguchi, Tetsuo, Morita, Toshisuke, Ono, Junya, Nunomura, Satoshi, Izuhara, Kenji, Sakamoto, Susumu, Homma, Sakae, Kishi, Kazuma
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 487
container_issue 6
container_start_page 479
container_title Respiratory investigation
container_volume 58
creator Isshiki, Takuma
Matsuyama, Hisayo
Yamaguchi, Tetsuo
Morita, Toshisuke
Ono, Junya
Nunomura, Satoshi
Izuhara, Kenji
Sakamoto, Susumu
Homma, Sakae
Kishi, Kazuma
description Some patients with sarcoidosis experience worsening of pulmonary lesions. However, no biomarker has been identified that reflects pulmonary disease status in sarcoidosis. We investigated the usefulness of potential markers of pulmonary fibrosis in patients with sarcoidosis. Plasma matrix metalloproteinase 7 (MMP-7), CC-chemokine ligand 18 (CCL-18), and periostin levels were evaluated in 60 patients with sarcoidosis and 30 healthy controls; bronchoalveolar lavage fluid levels were analyzed in 22 patients with sarcoidosis. To determine the usefulness of these markers, we explored potential correlations between these markers and sarcoidosis clinical characteristics. Plasma MMP-7, CCL-18, and periostin concentrations were significantly higher in patients with sarcoidosis than those in healthy controls. MMP-7 concentrations in plasma and bronchoalveolar lavage fluid were higher in patients with sarcoidosis with parenchymal infiltration than in those without lung lesions. Moreover, MMP-7 concentration was negatively correlated with pulmonary function. Among these novel biomarkers, MMP-7 most precisely reflected pulmonary sarcoidosis disease status and thus, might be useful for diagnosing and evaluating sarcoidosis, particularly in patients with pulmonary parenchymal lesions.
doi_str_mv 10.1016/j.resinv.2020.07.003
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2439624222</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2212534520301143</els_id><sourcerecordid>2439624222</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-7dfefec356d95d096aabcca9bfe3122c534826a565601790ef6ea247f2c2c4273</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0Eogj6Bwh5yYIEe5w4zQYJVbwkJFjA2nKdCbgkcfGkCP4eVwWWzObO4s7jHsaOpcilkPp8mUckP3zkIEDkosqFUDvsAEBCVqpS7f71RTlhU6KlSKVLKKTeZxMFMz0DXRyw_rGz1Fve2zH6T97jaLsurGIY0Q-WkFdnfD7P3Cv24c0PyDv_YoeGy9kZ3-gKow80-oFbSkviG0bibYh8te76MNj4xclGF3wTyNMR22ttRzj90UP2fH31NL_N7h9u7uaX95lTMz1mVdNii06VuqnLRtTa2oVztl60qCSAS6nS97bUpRayqgW2Gi0UVQsOXAGVOmSn270pyPsaaTS9J4ddZwcMazJQqFpDAQDJWmytLgaiiK1ZRZ-CfBkpzIa1WZota7NhbURlEus0dvJzYb3osfkb-iWbDBdbA6acHx6jIedxcNj4iG40TfD_X_gGpMuSsw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2439624222</pqid></control><display><type>article</type><title>Plasma matrix metalloproteinase 7, CC-chemokine ligand 18, and periostin as markers for pulmonary sarcoidosis</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Isshiki, Takuma ; Matsuyama, Hisayo ; Yamaguchi, Tetsuo ; Morita, Toshisuke ; Ono, Junya ; Nunomura, Satoshi ; Izuhara, Kenji ; Sakamoto, Susumu ; Homma, Sakae ; Kishi, Kazuma</creator><creatorcontrib>Isshiki, Takuma ; Matsuyama, Hisayo ; Yamaguchi, Tetsuo ; Morita, Toshisuke ; Ono, Junya ; Nunomura, Satoshi ; Izuhara, Kenji ; Sakamoto, Susumu ; Homma, Sakae ; Kishi, Kazuma</creatorcontrib><description>Some patients with sarcoidosis experience worsening of pulmonary lesions. However, no biomarker has been identified that reflects pulmonary disease status in sarcoidosis. We investigated the usefulness of potential markers of pulmonary fibrosis in patients with sarcoidosis. Plasma matrix metalloproteinase 7 (MMP-7), CC-chemokine ligand 18 (CCL-18), and periostin levels were evaluated in 60 patients with sarcoidosis and 30 healthy controls; bronchoalveolar lavage fluid levels were analyzed in 22 patients with sarcoidosis. To determine the usefulness of these markers, we explored potential correlations between these markers and sarcoidosis clinical characteristics. Plasma MMP-7, CCL-18, and periostin concentrations were significantly higher in patients with sarcoidosis than those in healthy controls. MMP-7 concentrations in plasma and bronchoalveolar lavage fluid were higher in patients with sarcoidosis with parenchymal infiltration than in those without lung lesions. Moreover, MMP-7 concentration was negatively correlated with pulmonary function. Among these novel biomarkers, MMP-7 most precisely reflected pulmonary sarcoidosis disease status and thus, might be useful for diagnosing and evaluating sarcoidosis, particularly in patients with pulmonary parenchymal lesions.</description><identifier>ISSN: 2212-5345</identifier><identifier>EISSN: 2212-5353</identifier><identifier>DOI: 10.1016/j.resinv.2020.07.003</identifier><identifier>PMID: 32868264</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Biomarkers - blood ; Bronchoalveolar Lavage Fluid ; CC-Chemokine ligand 18 ; Cell Adhesion Molecules - blood ; Chemokines, CC - blood ; Humans ; Ligands ; Matrix metalloproteinase 7 ; Matrix Metalloproteinase 7 - blood ; Periostin ; Pulmonary fibrosis ; Sarcoidosis ; Sarcoidosis, Pulmonary - diagnosis</subject><ispartof>Respiratory investigation, 2020-11, Vol.58 (6), p.479-487</ispartof><rights>2020 The Japanese Respiratory Society</rights><rights>Copyright © 2020 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-7dfefec356d95d096aabcca9bfe3122c534826a565601790ef6ea247f2c2c4273</citedby><cites>FETCH-LOGICAL-c386t-7dfefec356d95d096aabcca9bfe3122c534826a565601790ef6ea247f2c2c4273</cites><orcidid>0000-0002-1278-0943</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32868264$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Isshiki, Takuma</creatorcontrib><creatorcontrib>Matsuyama, Hisayo</creatorcontrib><creatorcontrib>Yamaguchi, Tetsuo</creatorcontrib><creatorcontrib>Morita, Toshisuke</creatorcontrib><creatorcontrib>Ono, Junya</creatorcontrib><creatorcontrib>Nunomura, Satoshi</creatorcontrib><creatorcontrib>Izuhara, Kenji</creatorcontrib><creatorcontrib>Sakamoto, Susumu</creatorcontrib><creatorcontrib>Homma, Sakae</creatorcontrib><creatorcontrib>Kishi, Kazuma</creatorcontrib><title>Plasma matrix metalloproteinase 7, CC-chemokine ligand 18, and periostin as markers for pulmonary sarcoidosis</title><title>Respiratory investigation</title><addtitle>Respir Investig</addtitle><description>Some patients with sarcoidosis experience worsening of pulmonary lesions. However, no biomarker has been identified that reflects pulmonary disease status in sarcoidosis. We investigated the usefulness of potential markers of pulmonary fibrosis in patients with sarcoidosis. Plasma matrix metalloproteinase 7 (MMP-7), CC-chemokine ligand 18 (CCL-18), and periostin levels were evaluated in 60 patients with sarcoidosis and 30 healthy controls; bronchoalveolar lavage fluid levels were analyzed in 22 patients with sarcoidosis. To determine the usefulness of these markers, we explored potential correlations between these markers and sarcoidosis clinical characteristics. Plasma MMP-7, CCL-18, and periostin concentrations were significantly higher in patients with sarcoidosis than those in healthy controls. MMP-7 concentrations in plasma and bronchoalveolar lavage fluid were higher in patients with sarcoidosis with parenchymal infiltration than in those without lung lesions. Moreover, MMP-7 concentration was negatively correlated with pulmonary function. Among these novel biomarkers, MMP-7 most precisely reflected pulmonary sarcoidosis disease status and thus, might be useful for diagnosing and evaluating sarcoidosis, particularly in patients with pulmonary parenchymal lesions.</description><subject>Biomarkers - blood</subject><subject>Bronchoalveolar Lavage Fluid</subject><subject>CC-Chemokine ligand 18</subject><subject>Cell Adhesion Molecules - blood</subject><subject>Chemokines, CC - blood</subject><subject>Humans</subject><subject>Ligands</subject><subject>Matrix metalloproteinase 7</subject><subject>Matrix Metalloproteinase 7 - blood</subject><subject>Periostin</subject><subject>Pulmonary fibrosis</subject><subject>Sarcoidosis</subject><subject>Sarcoidosis, Pulmonary - diagnosis</subject><issn>2212-5345</issn><issn>2212-5353</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtOwzAQRS0Eogj6Bwh5yYIEe5w4zQYJVbwkJFjA2nKdCbgkcfGkCP4eVwWWzObO4s7jHsaOpcilkPp8mUckP3zkIEDkosqFUDvsAEBCVqpS7f71RTlhU6KlSKVLKKTeZxMFMz0DXRyw_rGz1Fve2zH6T97jaLsurGIY0Q-WkFdnfD7P3Cv24c0PyDv_YoeGy9kZ3-gKow80-oFbSkviG0bibYh8te76MNj4xclGF3wTyNMR22ttRzj90UP2fH31NL_N7h9u7uaX95lTMz1mVdNii06VuqnLRtTa2oVztl60qCSAS6nS97bUpRayqgW2Gi0UVQsOXAGVOmSn270pyPsaaTS9J4ddZwcMazJQqFpDAQDJWmytLgaiiK1ZRZ-CfBkpzIa1WZota7NhbURlEus0dvJzYb3osfkb-iWbDBdbA6acHx6jIedxcNj4iG40TfD_X_gGpMuSsw</recordid><startdate>202011</startdate><enddate>202011</enddate><creator>Isshiki, Takuma</creator><creator>Matsuyama, Hisayo</creator><creator>Yamaguchi, Tetsuo</creator><creator>Morita, Toshisuke</creator><creator>Ono, Junya</creator><creator>Nunomura, Satoshi</creator><creator>Izuhara, Kenji</creator><creator>Sakamoto, Susumu</creator><creator>Homma, Sakae</creator><creator>Kishi, Kazuma</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1278-0943</orcidid></search><sort><creationdate>202011</creationdate><title>Plasma matrix metalloproteinase 7, CC-chemokine ligand 18, and periostin as markers for pulmonary sarcoidosis</title><author>Isshiki, Takuma ; Matsuyama, Hisayo ; Yamaguchi, Tetsuo ; Morita, Toshisuke ; Ono, Junya ; Nunomura, Satoshi ; Izuhara, Kenji ; Sakamoto, Susumu ; Homma, Sakae ; Kishi, Kazuma</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-7dfefec356d95d096aabcca9bfe3122c534826a565601790ef6ea247f2c2c4273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Biomarkers - blood</topic><topic>Bronchoalveolar Lavage Fluid</topic><topic>CC-Chemokine ligand 18</topic><topic>Cell Adhesion Molecules - blood</topic><topic>Chemokines, CC - blood</topic><topic>Humans</topic><topic>Ligands</topic><topic>Matrix metalloproteinase 7</topic><topic>Matrix Metalloproteinase 7 - blood</topic><topic>Periostin</topic><topic>Pulmonary fibrosis</topic><topic>Sarcoidosis</topic><topic>Sarcoidosis, Pulmonary - diagnosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Isshiki, Takuma</creatorcontrib><creatorcontrib>Matsuyama, Hisayo</creatorcontrib><creatorcontrib>Yamaguchi, Tetsuo</creatorcontrib><creatorcontrib>Morita, Toshisuke</creatorcontrib><creatorcontrib>Ono, Junya</creatorcontrib><creatorcontrib>Nunomura, Satoshi</creatorcontrib><creatorcontrib>Izuhara, Kenji</creatorcontrib><creatorcontrib>Sakamoto, Susumu</creatorcontrib><creatorcontrib>Homma, Sakae</creatorcontrib><creatorcontrib>Kishi, Kazuma</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Respiratory investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Isshiki, Takuma</au><au>Matsuyama, Hisayo</au><au>Yamaguchi, Tetsuo</au><au>Morita, Toshisuke</au><au>Ono, Junya</au><au>Nunomura, Satoshi</au><au>Izuhara, Kenji</au><au>Sakamoto, Susumu</au><au>Homma, Sakae</au><au>Kishi, Kazuma</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasma matrix metalloproteinase 7, CC-chemokine ligand 18, and periostin as markers for pulmonary sarcoidosis</atitle><jtitle>Respiratory investigation</jtitle><addtitle>Respir Investig</addtitle><date>2020-11</date><risdate>2020</risdate><volume>58</volume><issue>6</issue><spage>479</spage><epage>487</epage><pages>479-487</pages><issn>2212-5345</issn><eissn>2212-5353</eissn><abstract>Some patients with sarcoidosis experience worsening of pulmonary lesions. However, no biomarker has been identified that reflects pulmonary disease status in sarcoidosis. We investigated the usefulness of potential markers of pulmonary fibrosis in patients with sarcoidosis. Plasma matrix metalloproteinase 7 (MMP-7), CC-chemokine ligand 18 (CCL-18), and periostin levels were evaluated in 60 patients with sarcoidosis and 30 healthy controls; bronchoalveolar lavage fluid levels were analyzed in 22 patients with sarcoidosis. To determine the usefulness of these markers, we explored potential correlations between these markers and sarcoidosis clinical characteristics. Plasma MMP-7, CCL-18, and periostin concentrations were significantly higher in patients with sarcoidosis than those in healthy controls. MMP-7 concentrations in plasma and bronchoalveolar lavage fluid were higher in patients with sarcoidosis with parenchymal infiltration than in those without lung lesions. Moreover, MMP-7 concentration was negatively correlated with pulmonary function. Among these novel biomarkers, MMP-7 most precisely reflected pulmonary sarcoidosis disease status and thus, might be useful for diagnosing and evaluating sarcoidosis, particularly in patients with pulmonary parenchymal lesions.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>32868264</pmid><doi>10.1016/j.resinv.2020.07.003</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-1278-0943</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 2212-5345
ispartof Respiratory investigation, 2020-11, Vol.58 (6), p.479-487
issn 2212-5345
2212-5353
language eng
recordid cdi_proquest_miscellaneous_2439624222
source MEDLINE; Alma/SFX Local Collection
subjects Biomarkers - blood
Bronchoalveolar Lavage Fluid
CC-Chemokine ligand 18
Cell Adhesion Molecules - blood
Chemokines, CC - blood
Humans
Ligands
Matrix metalloproteinase 7
Matrix Metalloproteinase 7 - blood
Periostin
Pulmonary fibrosis
Sarcoidosis
Sarcoidosis, Pulmonary - diagnosis
title Plasma matrix metalloproteinase 7, CC-chemokine ligand 18, and periostin as markers for pulmonary sarcoidosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T17%3A17%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasma%20matrix%20metalloproteinase%207,%20CC-chemokine%20ligand%2018,%20and%20periostin%20as%20markers%20for%20pulmonary%20sarcoidosis&rft.jtitle=Respiratory%20investigation&rft.au=Isshiki,%20Takuma&rft.date=2020-11&rft.volume=58&rft.issue=6&rft.spage=479&rft.epage=487&rft.pages=479-487&rft.issn=2212-5345&rft.eissn=2212-5353&rft_id=info:doi/10.1016/j.resinv.2020.07.003&rft_dat=%3Cproquest_cross%3E2439624222%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2439624222&rft_id=info:pmid/32868264&rft_els_id=S2212534520301143&rfr_iscdi=true